- Home
- OACC vs GEVO Comparison
OACC vs GEVO Comparison
Compare OACC & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OACC
- GEVO
- Stock Information
- Founded
- OACC 2024
- GEVO 2005
- Country
- OACC United States
- GEVO United States
- Employees
- OACC N/A
- GEVO N/A
- Industry
- OACC
- GEVO Major Chemicals
- Sector
- OACC
- GEVO Industrials
- Exchange
- OACC NYSE
- GEVO Nasdaq
- Market Cap
- OACC 249.4M
- GEVO 285.1M
- IPO Year
- OACC 2024
- GEVO 2011
- Fundamental
- Price
- OACC $10.45
- GEVO $1.16
- Analyst Decision
- OACC
- GEVO Buy
- Analyst Count
- OACC 0
- GEVO 2
- Target Price
- OACC N/A
- GEVO $7.58
- AVG Volume (30 Days)
- OACC 78.0K
- GEVO 2.3M
- Earning Date
- OACC 01-01-0001
- GEVO 05-13-2025
- Dividend Yield
- OACC N/A
- GEVO N/A
- EPS Growth
- OACC N/A
- GEVO N/A
- EPS
- OACC N/A
- GEVO N/A
- Revenue
- OACC N/A
- GEVO $16,915,000.00
- Revenue This Year
- OACC N/A
- GEVO $617.82
- Revenue Next Year
- OACC N/A
- GEVO $84.22
- P/E Ratio
- OACC $96.45
- GEVO N/A
- Revenue Growth
- OACC N/A
- GEVO N/A
- 52 Week Low
- OACC $9.95
- GEVO $0.48
- 52 Week High
- OACC $10.85
- GEVO $3.39
- Technical
- Relative Strength Index (RSI)
- OACC N/A
- GEVO 51.71
- Support Level
- OACC N/A
- GEVO $1.00
- Resistance Level
- OACC N/A
- GEVO $1.14
- Average True Range (ATR)
- OACC 0.00
- GEVO 0.07
- MACD
- OACC 0.00
- GEVO 0.01
- Stochastic Oscillator
- OACC 0.00
- GEVO 69.57
About OACC OAKTREE ACQUISITION CORP III LIFE S
Oaktree Acquisition Corp III Life Sciences is a blank check company.
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.